Quantum Lab® applies cellular biotechnology to clinical practice in Mexico
We develop and supply cell lines and biological derivatives with traceability, documented quality control and scientific support for their responsible clinical integration.
Cellular biotechnology backed by experience and scientific evidence
Quantum Lab develops and releases cell preparations for professional use in regenerative medicine. We combine more than two decades of experience with technical control and scientific rigor in each cell line. Our MSC, DPSC, NK and exosomes lines are integrated into clinical practice under defined protocols, with academic support and continuous scientific monitoring.
Q-SUPPORT® EXOSOMES
(extracellular vesicles of MSC)
Purified preparation of vesicles 30-150 nm with a bioactive charge, for use as therapeutic adjunct in tissue repair and immunomodulation protocols.
- Origin and method. Characterized MSC derivatives; purification under controlled conditions.
- Characterization. CD63/CD81/CD9, size/count by NTA; sterility, mycoplasma and endotoxin testing.
- Use. Integration under protocol with scientific support for selection and management parameters.
Cell lines and derivatives with documented characterization
We develop and release cellular biomaterials for professional medical use.
Each line is characterized by defined markers and analytical tests, with technical documentation available and scientific support for its clinical implementation.

Stromal Precursors (MSC)
Mesenchymal cells characterized under the following criteria ISCTused as therapeutic adjunct for inflammatory and regenerative support in bone, joint and dermal tissues.

Dental Pulp Stem Cells (DPSC)
Population with mesenchymal profile obtained from human dental pulp, used in the manufacture of regenerative dentistry and oral and maxillofacial surgery. Application under defined protocol and specialized technical support.

Natural Killer (NK) Cells
Lymphocytes CD3-/CD56+ ex vivo expanded, with validated cytotoxic function and technical documentation per batch. Use under protocol in controlled clinical settings.
Science applied to medical practice
Our laboratory combines biotechnological knowledge with clinical expertise to offer cellular biomaterials ready for integration into medical protocols.
Each development is backed by documented characterization, analytical validations and ongoing scientific support.
Clinical areas of application
The following indications are examples of integration under protocol. Review specifications per line or request a case evaluation.
Regenerative dentistry
- Dental pulp regeneration
- Periodontal and alveolar bone repair
- Bone atrophy for implantology
- Peri-implant lesions
- Pulp revascularization in necrotic immature teeth
Lines: DPSC
Technical integration and specialized support
We facilitate the clinical incorporation of our cell preparations with technical support and personalized scientific follow-up.
Professional Application
Account registration and medical specialty to create your technical access profile.
Verification
ID, institution and corporate domain validation; credential activation.
Technical selection
Definition of cell line (MSC, DPSC, NK or Exosomes) and application parameters under protocol.
Logistics plan
Coordination of shipment, conservation and reception window according to product type.
Scientific support
Clinical integration consulting and post-delivery support.
Scientific publications and applied evidence
Research developed by Quantum Lab members in collaboration with academic institutions and clinical centers.
The results support the biological and analytical underpinnings of our cell lines.
Authors: Rosales-Ibáñez R., et al.
PCL-3D + DPSC for bone engineering (in vitro)
Application: evaluates the scaffold-cell-process trinomial to standardize bone formation. Polymers, 2021.
Authors: Rodríguez-Méndez I., Rosales-Ibáñez R., et al.
Sr(II)/chitosan/PCL scaffolds in craniofacials
Application: bioactive scaffold that improves osteoconduction; basis for combining with DPSC/MSC. Polymers, 2018.
Authors: Oliver-Urrutia C., Rosales-Ibáñez R., et al.
Lyophilized PVP hydrogel for oral mucosal cells
Application: stable matrix for cultivation/expansion; supports process feasibility and traceability. Materials, 2021.
Authors: Rosales-Ibáñez R., et al.
MWCNT/PCL seeded with DPSC to bone
Application: composite scaffold that enhances bone regeneration in vitro. J. Mater. Sci.: Mater. Med. 2016.
Authors: Hernández-Monjaraz B., Santiago-Osorio E., et al.
DPSC in periodontitis (mini-revision)
Application: mechanisms and clinical scope of DPSC in periodontal regeneration. Int. J. Mol. Sci., 2018.
Authors: Fajardo-Orduña G.R., Santiago-Osorio E., et al.
Bone marrow MSCs on a clinical scale
Application: differentiation, hematopoietic support and immunomodulation for clinical manufacturing. Stem Cells Dev, 2016.
Authors: Palma-Lara I., Parra-Barrera A., et al.
Epicatechin induces osteogenesis in human MSCs
Application: activates BMP2/RUNX2/SPARC; potential adjuvant in bone regeneration. J. Med. Food, 2025.
Authors: Peralta-Vega A.-B., Parra-Barrera A., Gutiérrez-Iglesias G., et al.
Toxicity of TiO₂ nanoparticles in MSC.
Application: evidence of cytotoxicity/oxidative stress; input for safety and QC criteria. Mol. & Cell. Toxicology, 2020.
